Atlas Trials

Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine

Clinical trial NCT05547815 · COMPLETED

Trial details

NCT number
NCT05547815
Sponsor
Changchun Zhuoyi Biological Co., Ltd
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
RabiesAntibody
Start date
2019-11-11
Primary completion
2020-12-17
Enrollment
149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.